Multi-Center Trial of GPX Embolic Device Enrolls Final Patient
Fluidx Medical completes enrollment in a multi-center trial for its embolic device, GPX, which has shown promising tumor embolization results.
Fluidx Medical completes enrollment in a multi-center trial for its embolic device, GPX, which has shown promising tumor embolization results.